MAPT and Alzheimer disease: We demonstrate that the anti-aggregation effects of PB on tau are sufficient to block seeding by AD patient-derived tau fibrils, in the cell-based tau biosensor seeding assays, but surprisingly, our data suggest that PB inhibits tau monomer aggregation without any disaggregating effects on existing tau fibrils.